Related Experiment Video
Updated: Jul 5, 2026

12:21
Generating Recombinant Avian Herpesvirus Vectors with CRISPR/Cas9 Gene Editing
Published on: January 7, 2019
HSV as a vector in vaccine development and gene therapy
Peggy Marconi1, Rafaela Argnani, Elena Berto
1Department of Experimental and Diagnostic Medicine, Section of Microbiology; University of Ferrara, Ferrara, Italy. mcy@unife.it
Human Vaccines
|May 24, 2008
Summary
Herpes simplex virus (HSV) genetics knowledge enables the creation of HSV-1 vectors for gene therapy and cancer treatment. These vectors offer potential for targeted delivery and prophylaxis against infections.
Area of Science:
- Genetics and Molecular Biology
- Virology
- Biotechnology
Background:
- Herpes simplex virus (HSV) is a significant human pathogen with a dual lifestyle involving lytic and latent infections.
- Extensive knowledge of HSV genetics and molecular biology has paved the way for therapeutic applications.
Purpose of the Study:
- To review the design, construction, and applications of HSV-1-based vectors.
- To discuss the potential and limitations of different HSV-1 vector classes.
Main Methods:
- Classification of HSV-1 vectors into three distinct categories: replication-competent attenuated, replication-incompetent recombinant, and defective helper-dependent (amplicons).
- Review of current literature on HSV-1 vector development and applications.
Main Results:
- HSV-1 vectors show promise for delivering genes to the nervous system.
- Applications include selective cancer cell destruction, prophylaxis against infections, and targeted tissue/organ infection.
- Three classes of HSV-1 vectors (attenuated, recombinant, amplicons) have been developed.
Conclusions:
- HSV-1-based vectors represent a versatile platform for various biomedical applications.
- Further research is needed to overcome current limitations and fully realize the potential of these vectors.
Related Concept Videos
Herpes
Herpes simplex type 1 (HSV‑1) is a widespread pathogen responsible for orolabial lesions. It is an enveloped, double-stranded DNA (dsDNA) virus belonging to the family Herpesviridae. Once the virus infects a host cell, its double‑stranded DNA genome is delivered into the nucleus, where a coordinated cascade of immediate‑early, early, and late gene expression directs viral DNA replication, structural protein synthesis, and virion assembly. After primary infection of epithelial cells, HSV-1...
Genital Herpes
Genital herpes is a sexually transmitted infection primarily caused by herpes simplex virus type 2 (HSV-2), though herpes simplex virus type 1 (HSV-1) is increasingly implicated in genital infections, particularly among younger populations. Transmission occurs mainly through sexual contact, with asymptomatic viral shedding serving as a major route of spread. This characteristic makes HSV-2 difficult to control at a population level, as individuals may unknowingly transmit the virus even in the...
Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
